FI960839A0 - Nya tripeptider, som är användbara i immun- och CNS-terapi - Google Patents

Nya tripeptider, som är användbara i immun- och CNS-terapi

Info

Publication number
FI960839A0
FI960839A0 FI960839A FI960839A FI960839A0 FI 960839 A0 FI960839 A0 FI 960839A0 FI 960839 A FI960839 A FI 960839A FI 960839 A FI960839 A FI 960839A FI 960839 A0 FI960839 A0 FI 960839A0
Authority
FI
Finland
Prior art keywords
immune
cns therapy
novel tripeptides
useful
tripeptides useful
Prior art date
Application number
FI960839A
Other languages
English (en)
Finnish (fi)
Other versions
FI960839A (sv
Inventor
Gideon Goldstein
Ponniah Shenbagamurthi
James I Koenig
Original Assignee
Immunobiology Res Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunobiology Res Inst Inc filed Critical Immunobiology Res Inst Inc
Publication of FI960839A publication Critical patent/FI960839A/sv
Publication of FI960839A0 publication Critical patent/FI960839A0/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C07K5/06095—Arg-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FI960839A 1993-08-26 1996-02-23 Nya tripeptider, som är användbara i immun- och CNS-terapi FI960839A0 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/112,413 US5639729A (en) 1993-08-26 1993-08-26 Tripeptides useful in immune and CNS therapy
PCT/US1994/009290 WO1995005841A1 (en) 1993-08-26 1994-08-17 Novel tripeptides useful in immune and cns therapy

Publications (2)

Publication Number Publication Date
FI960839A FI960839A (sv) 1996-02-23
FI960839A0 true FI960839A0 (sv) 1996-02-23

Family

ID=22343770

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960839A FI960839A0 (sv) 1993-08-26 1996-02-23 Nya tripeptider, som är användbara i immun- och CNS-terapi

Country Status (17)

Country Link
US (1) US5639729A (sv)
EP (1) EP0723454B1 (sv)
JP (1) JPH09502175A (sv)
KR (1) KR960703612A (sv)
CN (1) CN1133563A (sv)
AT (1) ATE207757T1 (sv)
BR (1) BR9407357A (sv)
CA (1) CA2169072A1 (sv)
CZ (1) CZ55496A3 (sv)
DE (1) DE69428909D1 (sv)
FI (1) FI960839A0 (sv)
HU (1) HUT73777A (sv)
IL (1) IL110585A0 (sv)
NO (1) NO960710L (sv)
PL (1) PL313257A1 (sv)
WO (1) WO1995005841A1 (sv)
ZA (1) ZA946008B (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4727770B2 (ja) * 1997-09-26 2011-07-20 カルピス株式会社 尿中カテコールアミン低下、尿中ノルアドレナリン低下、尿中ドーパミン低下及びＦｉｓｃｈｅｒ比低下の少なくとも１つの軽減剤
ATE435852T1 (de) 2001-05-24 2009-07-15 Neuren Pharmaceuticals Ltd Gpe-analoga und peptidomimetika
US7714020B2 (en) * 2001-05-24 2010-05-11 Neuren Pharmaceuticals Limited Treatment of non-convulsive seizures in brain injury using G-2-methyl-prolyl glutamate
US7605177B2 (en) * 2001-05-24 2009-10-20 Neuren Pharmaceuticals Limited Effects of glycyl-2 methyl prolyl glutamate on neurodegeneration
US20070004641A1 (en) * 2001-05-24 2007-01-04 Neuren Pharmaceuticals Limited Cognitive enhancement and cognitive therapy using glycyl-L-2-methylprolyl-L-glutamate
SG187271A1 (en) * 2011-07-07 2013-02-28 Agency Science Tech & Res Anti-amyloidogenic, alpha-helix breaking ultra-small peptide therapeutic

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4190646A (en) * 1975-11-11 1980-02-26 Sloan-Kettering Institute For Cancer Research Polypeptide compositions and methods
US4505853A (en) * 1983-11-18 1985-03-19 Ortho Pharmaceutical Corporation Enzyme-resistant immunomodulatory peptides
US4629723A (en) * 1984-06-27 1986-12-16 Ortho Pharmaceutical Corporation Potent thymopentin analogs
US5028592A (en) * 1986-08-08 1991-07-02 Lipton James M Antipyretic and anti-inflammatory peptides
IT1216908B (it) * 1987-03-19 1990-03-14 Eniricerche Spa Analoghi retro-inversi della timopentina e dei suoi frammenti, il metodo per la loro sintesi ed il loro impiego per la preparazionedi composizioni farmaceutiche.
IT1222437B (it) * 1987-08-04 1990-09-05 Ellem Ind Farmaceutica Tripeptidi utili come immunostimolanti e nella prevenzione delle metastasi e relativo procedimento di preparazione
NZ229004A (en) * 1988-05-19 1993-09-27 Immunobiology Res Inst Inc Tetrapeptides having t cell helper acitivity
HU201095B (en) * 1988-06-14 1990-09-28 Richter Gedeon Vegyeszet New peptides inhibiting the activity of the immune system and pharmaceutical compositions comprising same, as well as process for producing these peptides and compositions
KR900701298A (ko) * 1988-09-30 1990-12-01 원본미기재 T-세포 억제작용을 보유한 펩티드
DD296084A5 (de) * 1989-07-27 1991-11-21 Adw Verfahren zur herstellung von humanen spleninderivaten

Also Published As

Publication number Publication date
AU7868194A (en) 1995-03-21
HUT73777A (en) 1996-09-30
FI960839A (sv) 1996-02-23
CZ55496A3 (en) 1996-08-14
NO960710D0 (no) 1996-02-22
US5639729A (en) 1997-06-17
JPH09502175A (ja) 1997-03-04
ATE207757T1 (de) 2001-11-15
CN1133563A (zh) 1996-10-16
DE69428909D1 (de) 2001-12-06
NO960710L (no) 1996-02-22
IL110585A0 (en) 1994-11-11
EP0723454A4 (en) 1998-07-29
ZA946008B (en) 1995-03-29
HU9600432D0 (en) 1996-04-29
KR960703612A (ko) 1996-08-31
CA2169072A1 (en) 1995-03-02
EP0723454A1 (en) 1996-07-31
PL313257A1 (en) 1996-06-24
BR9407357A (pt) 1996-10-29
EP0723454B1 (en) 2001-10-31
WO1995005841A1 (en) 1995-03-02
AU682898B2 (en) 1997-10-23

Similar Documents

Publication Publication Date Title
AU693747B2 (en) Imidazo(4,5-c)pyridin-4-amines
ES2156852T3 (es) Citoquina mamifera, il-11.
IL110284A0 (en) Viral vectors and their use in gene therapy
ES8801930A1 (es) Procedimiento para la preparacion de dipeptidos de n,n'-dialquilguanidino
ATE259828T1 (de) Prosaposin und cytokinabhängige peptide als therapeutisch wirksame mittel
CA2075060A1 (en) Novel vehicle gases and their use in medical preparations
ATE347585T1 (de) In-vitro wachstum von langerhans'schen inseln und ihre verwendungen
DE69431060D1 (de) Klonierte glutaminsäure-decarboxylase
IL110754A0 (en) Cell compositions preparation and therapeutic uses
BG103664A (en) Pharmaceutical forms containing ammoxycillin and clavulanate
DE3586697D1 (en) Aktive thymopentin-analoga.
ATE255632T1 (de) Immortalisierung bzw. desimmortalisierung von zellen
MX9602557A (es) Proteinas de higado de mamifero y su uso en oncologia.
FI960839A (sv) Nya tripeptider, som är användbara i immun- och CNS-terapi
ZA894013B (en) Combination of angiotensin converting enzyme inhibitors with potassium channel modulators and use thereof in pharmaceuticals
MY129947A (en) Novel substituted thienopyrans as antihypertensive agents.
EP0160486A3 (en) Monoclonal antibodies
DK222988D0 (da) Farmaceutiske praeparater indeholdende ornithin-decarboxylase-inhibitorer
DE69534740D1 (en) Analoge des thymosin alpha 1
TW346397B (en) Cell cycle controlling compositions and methods of using same
WO1994021273A3 (de) VERWENDUNG VON ANGIOGENIN UND/ODER α1-MICROGLOBULIN UND/ODER KOMPLEMENTFAKTOR D ZUR BEGRENZUNG DER SEKRETION VON PROTEINEN
RU93005016A (ru) Иммунорегуляторные и нейрорегуляторные пентапептиды, фармацевтические композиции на их основе, способ получения пентапептидов, способ лечения
MX9802380A (es) Formas cortas de quimiocina beta-8.

Legal Events

Date Code Title Description
FD Application lapsed